Spring til hovednavigation
Spring til søgning
Spring til hovedindhold
Sorter
Keyphrases
Frontotemporal Dementia
100%
CHMP2B
100%
Serum Neurofilament Light
100%
Asymptomatic Carriers
50%
Neurofilament Light (NF-L)
37%
Clinical Group
37%
Non-carriers
25%
Mutation Carriers
25%
Serum Albumin
25%
Albumin Ratio
25%
Light Level
25%
Surrogate Marker
12%
Neurodegenerative Diseases
12%
Autosomal Dominant
12%
Blood-brain Barrier
12%
Blood-brain Barrier Disruption
12%
Clinical Parameters
12%
Blood Biomarkers
12%
Microarray Technology
12%
Family Control
12%
Clinical Utility
12%
Barrier Function
12%
CSF Levels
12%
Light Concentration
12%
Light Dynamics
12%
Group Parameters
12%
Familial FTD
12%
ACE Score
12%
Single Molecule Array (SIMOA)
12%
Healthy Families
12%
Pharmacology, Toxicology and Pharmaceutical Science
Frontotemporal Dementia
100%
Serum Albumin
100%
Blood-Brain Barrier
100%
Disease Marker
50%
Biological Marker
50%
Degenerative Disease
50%
Cross-Sectional Study
50%
Biochemistry, Genetics and Molecular Biology
CHMP2B
100%
Neurofilament Light
100%
Blood Brain Barrier
18%
Serum Albumin
18%
Cross Sectional Study
9%
Autosomal Dominant Inheritance
9%
Neuroscience
Frontotemporal Dementia
100%
Neurofilament
100%
Blood Brain Barrier
18%
Serum Albumin
18%
Neurodegenerative Disorder
9%
Biological Marker
9%